Could insulin jabs boost brain power in Alzheimer's?
NCT ID NCT07265323
First seen Dec 15, 2025 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This study is testing whether giving insulin through a vein every five minutes for two hours, once a week for six months, can improve how the body uses sugar and how well people with Alzheimer's think. Eight adults with mild to moderate Alzheimer's will take part. The goal is to see if this approach is safe and can boost memory and brain function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pennington Biomedical Research Center
RECRUITINGBaton Rouge, Louisiana, 70806, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
insulin infusion
What this could lead to
If it works, this could point toward a new way to improve thinking and memory in people with Alzheimer's disease.
What could go wrong
This is a very small, early-stage trial with only 8 participants, so results may not apply widely. The frequent infusions are also time-intensive and may not be practical long-term.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.